Continuus Pharmaceuticals, Inc. announced that it has received $5,000,041 in an equity round of funding led by new investor Mark Bamforth on August 26, 2019. The transaction included participation from returning investor I.M.A. Industria Macchine Automatiche S.p.A. (BIT:IMA) and other returning investors. As a part of transaction, Mark Bamforth will join company’s board of directors. The company has raised funding pursuant to exemption provided under Regulation D from 20 investors, which includes 3 non-accredited investors.